A2 Milk's Potential Earnings Upgrades Has Multiple Drivers -- Market Talk

Dow Jones04-10

0032 GMT - Morgan Stanley identifies three potential drivers of incremental earnings upgrades by A2 Milk. Analyst Julia M. de Sterke says earlier regulatory approvals for two China Label products could pull forward the ramp-up in production from A2 Milk's Pokeno plant in New Zealand. That would improve profitability sooner than expected, and potentially lead to A2 Milk declaring a special dividend early. Secondly, MS says growth in categories such as supplements could add a complementary, non margin-dilutive stream alongside infant milk formula. "A2 Platinum/Genesis could see incremental share gains as competitors work through recall-driven disruption, with notably Nestle a potential net share donor given recent soft commentary on the China market," MS says. It thinks these factors combined could benefit FY27 Ebitda by 23%. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

April 09, 2026 20:32 ET (00:32 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626151612?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-10 08:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626151612","market":"us","top_or_hot":-1,"title":"A2 Milk's Potential Earnings Upgrades Has Multiple Drivers -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0032 GMT - Morgan Stanley identifies three potential drivers of incremental earnings upgrades by <a href=\"https://laohu8.com/S/ACOPF\">A2 Milk</a>. Analyst Julia M. de Sterke says earlier regulatory approvals for two China Label products could pull forward the ramp-up in production from <a href=\"https://laohu8.com/S/A2M.AU\">A2 Milk</a>'s Pokeno plant in New Zealand. That would improve profitability sooner than expected, and potentially lead to A2 Milk declaring a special dividend early. Secondly, MS says growth in categories such as supplements could add a complementary, non margin-dilutive stream alongside infant milk formula. \"A2 Platinum/Genesis could see incremental share gains as competitors work through recall-driven disruption, with notably Nestle a potential net share donor given recent soft commentary on the China market,\" MS says. It thinks these factors combined could benefit FY27 Ebitda by 23%. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 09, 2026 20:32 ET (00:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A2 Milk's Potential Earnings Upgrades Has Multiple Drivers -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA2 Milk's Potential Earnings Upgrades Has Multiple Drivers -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-10 08:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0032 GMT - Morgan Stanley identifies three potential drivers of incremental earnings upgrades by <a href=\"https://laohu8.com/S/ACOPF\">A2 Milk</a>. Analyst Julia M. de Sterke says earlier regulatory approvals for two China Label products could pull forward the ramp-up in production from <a href=\"https://laohu8.com/S/A2M.AU\">A2 Milk</a>'s Pokeno plant in New Zealand. That would improve profitability sooner than expected, and potentially lead to A2 Milk declaring a special dividend early. Secondly, MS says growth in categories such as supplements could add a complementary, non margin-dilutive stream alongside infant milk formula. \"A2 Platinum/Genesis could see incremental share gains as competitors work through recall-driven disruption, with notably Nestle a potential net share donor given recent soft commentary on the China market,\" MS says. It thinks these factors combined could benefit FY27 Ebitda by 23%. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 09, 2026 20:32 ET (00:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATM.NZ","symbol_name":"The a2 Milk Company Limited Ordinary Shares","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2626151612","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2626151612","pubTimestamp":1775781120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0032 GMT - Morgan Stanley identifies three potential drivers of incremental earnings upgrades by A2 Milk. Analyst Julia M. de Sterke says earlier regulatory approvals for two China Label products could pull forward the ramp-up in production from A2 Milk's Pokeno plant in New Zealand. That would improve profitability sooner than expected, and potentially lead to A2 Milk declaring a special dividend early. Secondly, MS says growth in categories such as supplements could add a complementary, non margin-dilutive stream alongside infant milk formula. \"A2 Platinum/Genesis could see incremental share gains as competitors work through recall-driven disruption, with notably Nestle a potential net share donor given recent soft commentary on the China market,\" MS says. It thinks these factors combined could benefit FY27 Ebitda by 23%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate","earning"],"viewcount":null,"language":"en","relate_stocks":{"ATM.NZ":"The a2 Milk Company Limited Ordinary Shares"},"translate_title":"A2 Milk潜在的盈利升级有多种驱动因素——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATM.NZ":1.5},"content_text":"0032 GMT - Morgan Stanley identifies three potential drivers of incremental earnings upgrades by A2 Milk. Analyst Julia M. de Sterke says earlier regulatory approvals for two China Label products could pull forward the ramp-up in production from A2 Milk's Pokeno plant in New Zealand. That would improve profitability sooner than expected, and potentially lead to A2 Milk declaring a special dividend early. Secondly, MS says growth in categories such as supplements could add a complementary, non margin-dilutive stream alongside infant milk formula. \"A2 Platinum/Genesis could see incremental share gains as competitors work through recall-driven disruption, with notably Nestle a potential net share donor given recent soft commentary on the China market,\" MS says. It thinks these factors combined could benefit FY27 Ebitda by 23%. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 09, 2026 20:32 ET (00:32 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626151612","isCrawlerRequest":true}